UK markets closed

Hemogenyx Pharmaceuticals Plc (HEMO.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.5650-0.0020 (-0.13%)
At close: 04:20PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 21.03M
Enterprise value 22.72M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.46
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.96

Trading information

Stock price history

Beta (5Y monthly) 3.03
52-week change 3-22.62%
S&P500 52-week change 322.43%
52-week high 37.1340
52-week low 31.1000
50-day moving average 31.8140
200-day moving average 32.1409

Share statistics

Avg vol (3-month) 315.73M
Avg vol (10-day) 34.9M
Shares outstanding 51.34B
Implied shares outstanding 61.34B
Float 81.07B
% held by insiders 110.73%
% held by institutions 10.82%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-61.24%
Return on equity (ttm)-222.31%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -5.82M
Net income avi to common (ttm)-6.69M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.25M
Total cash per share (mrq)0
Total debt (mrq)2.95M
Total debt/equity (mrq)105.93%
Current ratio (mrq)3.33
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-6.11M
Levered free cash flow (ttm)-4.37M